October 8, 2025 · Form 4 insider transaction
Bodenstedt Matthias bought 10,870 shares of MOONLAKE THERAPEUTICS at $9.09 per share, a transaction worth $98.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $9.085 to $9.091244. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.